189 related articles for article (PubMed ID: 4608018)
1. Comments on the UGDP study.
Schöffling K
Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
[No Abstract] [Full Text] [Related]
2. The UGDP--tolbutamide and mortality.
Knowles HC
Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
[No Abstract] [Full Text] [Related]
3. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
Pirart J
Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448
[No Abstract] [Full Text] [Related]
4. The UGDP study.
Salsburg DS
JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
[No Abstract] [Full Text] [Related]
5. Editorial: Oral hypoglycemic drugs.
Scoville AB
J Tenn Med Assoc; 1975 Apr; 68(4):319-20. PubMed ID: 1117723
[No Abstract] [Full Text] [Related]
6. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
7. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).
Seltzer HS
Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722
[No Abstract] [Full Text] [Related]
8. The UGDP controversy. Clinical trials versus clinical impressions.
Prout TE; Knatterud GL; Meinert CL; Klimt CR
Diabetes; 1972 Oct; 21(10):1035-40. PubMed ID: 4561330
[No Abstract] [Full Text] [Related]
9. Audit confirms conclusions of UGDP study on oral diabetes drugs.
FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):34-6. PubMed ID: 720789
[No Abstract] [Full Text] [Related]
10. Antidiabetic agents and vascular events.
Keen H
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():99-105. PubMed ID: 783218
[No Abstract] [Full Text] [Related]
11. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
[No Abstract] [Full Text] [Related]
12. [Oral therapy in diabetes].
Kirkeby K
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1620-1. PubMed ID: 4588817
[No Abstract] [Full Text] [Related]
13. Therapy of type 2 diabetes, cardiovascular death, and the UGDP.
Feinglos MN; Bethel MA
Am Heart J; 1999 Nov; 138(5 Pt 1):S346-52. PubMed ID: 10539796
[No Abstract] [Full Text] [Related]
14. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
[No Abstract] [Full Text] [Related]
15. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
Polosa P; Mughini L
Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
[No Abstract] [Full Text] [Related]
16. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
Kilo C; Miller JP; Williamson JR
Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693
[No Abstract] [Full Text] [Related]
17. Letter: Oral hypoglycaemics in diabetes mellitus.
Keen H; Jarrett RJ; Fuller JH
Lancet; 1975 Nov; 2(7940):865. PubMed ID: 53342
[No Abstract] [Full Text] [Related]
18. A progress report on the University Group Diabetes Program.
Prout TE
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369
[TBL] [Abstract][Full Text] [Related]
19. [Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged].
Teuscher A
Schweiz Med Wochenschr; 1972 Jun; 102(24):848-55. PubMed ID: 5033623
[No Abstract] [Full Text] [Related]
20. [Causes of death in diabetes mellitus].
Akhmetzianov AM; Mazovetskiĭ AG; Kliachko VR
Probl Endokrinol (Mosk); 1975; 21(1):103-11. PubMed ID: 1094446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
